According to a report from Oriental Tobacco News, in May, Wang Gongcheng, Deputy Director of the State Tobacco Monopoly Administration, held consecutive meetings in Beijing with senior representatives from Japan Tobacco International, British American Tobacco, and Philip Morris International (PMI).
On May 7th, Wang Gongcheng, a member of the Party group and deputy director of the State Tobacco Monopoly Administration, met with the visiting President of Japan Tobacco International Asia-Pacific, Bob Yi, in Beijing. The two sides had a friendly meeting. Officials from the State Administration's Office (Foreign Affairs Department), Development Planning Department, China National Tobacco Corporation, and China Tobacco International Group Co., Ltd. also attended the meeting.
On May 16, Wang Gongcheng, a member of the party group and deputy director of the State Tobacco Monopoly Administration, met with members of the British American Tobacco Group Management Committee, including Di Giacomo Nocsk, President of the Asia-Pacific, Middle East, and Africa region, in Beijing. The two sides held friendly discussions. Participants in the meeting included officials from the State Administration Office (Foreign Affairs Department), Development Planning Department, e-cigarette management office, China Tobacco Sales Corporation, and China Tobacco International Limited.
On May 21, Wang Gongcheng, member of the Party group and deputy director of the State Tobacco Monopoly Administration, met with Philip Morris International (PMI) China's Chief Strategic Cooperation Officer Chen Jingyi and her delegation in Beijing. The two sides had a friendly discussion. Officials from the State Administration's Office (Foreign Affairs Department), Development Planning Department, Economic Operations Department, China Tobacco Sales Corporation, and China Tobacco International Limited were present at the meeting.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
